CNAM
CPRX icon

Campbell Newman Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Campbell Newman Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29M Buy
92,476
+1,559
+2% +$37.1K 0.19% 57
2025
Q4 		$2.12M Sell
90,917
-3,449
-4% -$76.8K 0.16% 63
2025
Q3 		$1.86M Buy
94,366
+398
+0.4% +$8.19K 0.14% 73
2025
Q2 		$2.04M Buy
93,968
+6,233
+7% +$147K 0.16% 66
2025
Q1 		$2.13M Sell
87,735
-390
-0.4% -$8.78K 0.18% 60
2024
Q4 		$1.84M Sell
88,125
-218
-0.2% -$4.68K 0.15% 68
2024
Q3 		$1.76M Sell
88,343
-1,440
-2% -$26.7K 0.13% 74
2024
Q2 		$1.39M Buy
89,783
+311
+0.3% +$4.84K 0.11% 79
2024
Q1 		$1.43M Buy
+89,472
New +$1.35M 0.12% 78

Other funds holding CPRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM